See the Supplemental Experimental Procedures for details. To coimmunoprecipitate EBAX-1 and SAX-3, HEK293T cells transfected with indicated constructs for ∼24 hr were treated with 1 μM bortezomib or 25 μM MG132 for 2 hr and collected in lysis buffer (50 mM Tris [pH 7.0], 150 mM NaCl,
0.5 mM EDTA, and 0.5% NP-50) supplied with protease inhibitors. The lysates were incubated on ice for 30 min and then cleared by centrifugation at 4°C (14,000 rpm, 10 min). The supernatants were incubated with mouse anti-Flag M2 antibodies (Sigma) or mouse IgG for Enzalutamide 4 hr at 4°C, followed by incubation with Protein G agarose beads (Pierce) for 1 hr at 4°C. Protein G beads were then washed with 5 × 1.5 ml lysis buffer and boiled in SDS loading buffer for 15 min at 85°C. Rabbit anti-V5 and HRP-conjugated mouse anti-Flag antibodies (Sigma) were used for immunoblotting. To pulse-chase the degradation of SAX-3(WT)
and SAX-3(P37S), HEK293T cells were transfected with indicated constructs. The next day, transfected cells were treated with 1 μM cycloheximide to block protein synthesis for 0, 2, 4, or 6 hr. Cells were collected in lysis buffer DAPT concentration ∼24 hr after transfection and incubated on ice for 30 min before clearing by centrifugation at 4°C (14,000 rpm, 10 min). Equal amounts of supernatants from different time points were denatured by SDS loading buffer for immunoblotting. A two-tailed Student’s t test was used for comparisons of two groups.
One-way ANOVA with a Bonferroni or Dunnett posttest was used to compare multiple groups. We are grateful to Larry Zipursky for generously sharing unpublished results of Drosophila CG34401 mutants, leading us to work on ebax-1 in C. elegans, and to Aljoscha Nern and Marta Morey-Ramonell for personal communications. We thank David King at the Howard Hughes Medical Institute Mass Spectrometry Lab at UC Berkeley for mass spectrometry analyses. Shohei Mitani, the C. elegans Gene Knockout Consortium, and the Caenorhabditis Genetics Center provided too mutant strains. We thank Cori Bargmann, Gian Garriga, Ian Chin-Sang, Ed Kipreos, William Wadsworth, Xiaofeng Xin, and Charlie Boone for reagents. We value discussions with Randy Hampton, James Moresco, and our lab members. Z.W. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research, and X.G. was supported by a postdoctoral fellowship from the Susan G. Komen breast cancer foundation. This work was partly supported by awards from the National Institutes of Health (R01 NS057317 to A.D.C.; Y.J.; R01 NS 035546 to Y.J.). M.B. was supported by a Netherlands Organization for Scientific Research Vidi grant. Y. J. is an investigator of the Howard Hughes Medical Institute.